NEW YORK, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Global Chronic Idiopathic Constipation (CIC) Drugs Market is estimated to reach $2.96 billion by 2024 Says, Profshare Market Research; growing at a CAGR of 6.6% between 2016 and 2024.If the constipation happens chronically with an unidentifiable cause it is known as Chronic Idiopathic Constipation (CIC). The word “Idiopathic” means the cause is not known. Increasing awareness and widespread presence of idiopathic constipation are the key factors for growth of CIC drugs market. Currently CIC drugs market has huge opportunity for research and development.

Depending on type of drugs, global CIC drugs market is segmented into Lubiprostone, Linaclotide and others. Currently Lubiprostone drug segment dominates the market. But, due to its lower efficacy in comparison with others, patent loss and growing competition from Linaclotide, Lubiprostone will lose its dominance in the upcoming future. Depending on prescription types it is subdivided into prescribed drugs and over the counter drugs. After analysing the symptoms also, constipation is not considered as a disease but a condition, side effect or syndrome. Usually patients avoid to visit doctors to address the issue. Therefore approximately 65% of the CIC drugs market is covered by over the counter drugs. The top players of CIC drugs market are Actavis, Chugai Pharmaceutical, Ferring International Center S.A., Synergy Pharmaceuticals, Pfizer, GlaxoSmithKline, Roche Holding AG, Sanofi, Bayer AG, Salix Pharmaceuticals Ltd, Sucampo Pharmaceuticals Inc, Ironwood Pharmaceuticals and Progenics Pharmaceuticals.

Get Free Sample: https://www.profsharemarketresearch.com/sample/chronic-idiopathic-constipation-cic-drugs-market-sample/

Global Chronic Idiopathic Constipation (CIC) Drugs Market: End Users/Application Analysis

• Hospitals & Clinics
  
  
• Ambulatory Surgical Centres
  
  
• Long Term Care Centres

Global Chronic Idiopathic Constipation (CIC) Drugs Market: Product Type

• Lubiprostone
  
  
• Linaclotide

Report Enquiry: https://www.profsharemarketresearch.com/enquiry/chronic-idiopathic-constipation-cic-drugs-market-enquiry/

Global Chronic Idiopathic Constipation (CIC) Drugs Market: Competitive Analysis

Report includes accurate analysis of key players with Market Value, Company profile, SWOT analysis. The Study constitutes of following key players in Chronic Idiopathic Constipation (CIC) Drugs:

• Actavis
  
  
• Chugai Pharmaceutical
  
  
• Ferring International Center S.A.
  
  
• Synergy Pharmaceuticals
  
  
• Pfizer
  
  
• GlaxoSmithKline
  
  
• Roche Holding AG
  
  
• Sanofi
  
  
• Bayer AG
  
  
• Salix Pharmaceuticals Ltd
  
  
• Sucampo Pharmaceuticals Inc
  
  
• Ironwood Pharmaceuticals
  
  
• Progenics Pharmaceuticals

Buy Report: https://www.profsharemarketresearch.com/buy/chronic-idiopathic-constipation-cic-drugs-market-buy-su/

Contact Us:

Mia Cox,

Email- sales@profsharemarketresearch.com

Tel- 1-877-797-7295

www.profsharemarketresearch.com

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.